<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03248414</url>
  </required_header>
  <id_info>
    <org_study_id>B-1511/324-002</org_study_id>
    <nct_id>NCT03248414</nct_id>
  </id_info>
  <brief_title>Investigation of Anti-obesity Properties of Lactobacillus Sakei in Obese Human Subjects</brief_title>
  <official_title>Investigation of Anti-obesity Properties of Lactobacillus Sakei in Obese Human Subjects</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Bundang Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Bundang Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this study, we are going to investigate the efficacy of Lactobacillus Sakei on reduction
      of fat mass assessed by DEXA compared to plaebo.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      We are going to enroll subjects whose BMI is equal to higher than 25, and randomly assigned
      study material or placebo at 1:1 ratio. The treatment duration is 12 weeks.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 10, 2016</start_date>
  <completion_date type="Actual">September 10, 2018</completion_date>
  <primary_completion_date type="Actual">June 10, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
    <masking_description>Double blinded</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Fat mass change in 12-week</measure>
    <time_frame>12 weeks</time_frame>
    <description>fat mass is measured by DEXA</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Changes in body weight</measure>
    <time_frame>12 weeks</time_frame>
    <description>body weight change</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in waist circumference</measure>
    <time_frame>12 weeks</time_frame>
    <description>Waist circumference change</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Glucose metabolism</measure>
    <time_frame>12 weeks</time_frame>
    <description>Changes in HbA1c</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Glucose metabolism</measure>
    <time_frame>12 weeks</time_frame>
    <description>Changes in fasting glucose concentration</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Glucose metabolism</measure>
    <time_frame>12 weeks</time_frame>
    <description>Changes in insulin resistance</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Glucose metabolism</measure>
    <time_frame>12 weeks</time_frame>
    <description>Changes in beta-cell function</description>
  </secondary_outcome>
  <other_outcome>
    <measure>GI adverse effect</measure>
    <time_frame>12 weeks</time_frame>
    <description>incidence of gastrointestinal discomfort</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">114</enrollment>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>Lactobacillus sakei</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>2 packs per day</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>2 packs per day</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Lactobacillus sakei</intervention_name>
    <description>1 pack contained 5 x 109 cfu</description>
    <arm_group_label>Control</arm_group_label>
    <arm_group_label>Lactobacillus sakei</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age 20-65 years

          -  BMI equal to higher than 25 kg/m2

        Exclusion Criteria:

          -  under anti-obesity medication

          -  uncontrolled diabetes

          -  uncontrolled hypertension

          -  any medications can influence to body weight such as thiazolidinedione, GLP-1
             analogue, SGLT2 inhibitor, diuretics

          -  thyroid function test abnormality

          -  malignancy within 5 years

          -  immune compromised hosts or under immune suppressants

          -  antibiotics or probiotics withing 2 weeks

          -  any intervention to reduce body weight within 6 months
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Seoul National University Bundang Hospital</name>
      <address>
        <city>Seongnam</city>
        <state>Gyeonggi</state>
        <zip>463-707</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>September 2018</verification_date>
  <study_first_submitted>August 9, 2017</study_first_submitted>
  <study_first_submitted_qc>August 9, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">August 14, 2017</study_first_posted>
  <last_update_submitted>September 9, 2018</last_update_submitted>
  <last_update_submitted_qc>September 9, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">September 11, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Bundang Hospital</investigator_affiliation>
    <investigator_full_name>Soo Lim</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Obesity</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

